Global Market for Rare Disease Genetic Testing: Next-Generation Sequencing (NGS), Array Technology, PCR-Based Tests, Fluorescence In Situ Hybridization...
This research report (Global Rare Disease Genetic Testing Market) investigates and analyzes the current state and outlook for the global market of rare disease genetic testing over the next five years. It includes information on the overview of the global rare disease genetic testing market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis.
The segments by type in the rare disease genetic testing market include next-generation sequencing (NGS), array technology, PCR-based tests, fluorescence in situ hybridization (FISH), Sanger sequencing, karyotyping, and others. The segments by application cover laboratories/CROs, diagnostic laboratories, hospitals/clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for rare disease genetic testing.
The report also includes the market share of major companies in rare disease genetic testing, product and business overviews, and sales performance.